Thursday, October 30, 2008
Wednesday, October 22, 2008
OCTOBER Fact of the Month
All DBBS applicants must travel to St. Louis for a personal interview.
If an applicant is not available to travel to St. Louis for an interview during mid-January to mid-March, their application will not be considered. All interviews are by invitation only. Interviews are not conducted prior to submission and evaluation of an application. Most travel costs within the U.S. will be paid by DBBS. Telephone interviews are not permitted in substitution of a personal interview.
All DBBS applicants must travel to St. Louis for a personal interview.
If an applicant is not available to travel to St. Louis for an interview during mid-January to mid-March, their application will not be considered. All interviews are by invitation only. Interviews are not conducted prior to submission and evaluation of an application. Most travel costs within the U.S. will be paid by DBBS. Telephone interviews are not permitted in substitution of a personal interview.2009 Interview Dates:
Biochemistry - January 23 and February 20
Biophysics - February 6 and February 20
Computational Biology - February 6 and February 27
Developmental Biology - February 6 and February 20
Evolution, Ecology and Population Biology - February 13 and March 6
Genetics and Genomics - January 30, February 13 and February 27
Human and Statistical Genetics - February 13 and February 27
Immunology - February 20 and March 6
Molecular Cell Biology - January 23, February 20 and March 6
Microbiology - January 23, February 6 and February 27
Neurosciences - January 30, February 13, and March 27, 2009: Revisit opportunity for accepted students
Plant Biology - January 30 and February 27
Friday, October 17, 2008
Two DBBS Faculty Named to Institute of Medicine
Jeffrey I. Gordon, M.D., and David M. Holtzman, M.D., were recognized for their major contributions to the advancement of the medical sciences, health care and public health and commitment to service.
Gordon is the Dr. Robert J. Glaser Distinguished University Professor and director of the Center for Genome Sciences, and Holtzman is the Andrew B. and Gretchen P. Jones Professor and chair of the Department of Neurology.
Gordon is internationally known for his research on gut development and how gut microbes affect normal intestinal function, and predisposition to health and to certain diseases. His research has shown that our gut microbes are biomarkers, mediators and potential therapeutic targets in the war against the worldwide obesity epidemic. By sequencing the genes present in gut microbial communities of obese and lean mice, and by observing the effects of transplanting these communities into germ-free mice, he has shown that microbial communities from obese mice have an increased capacity to harvest calories from the diet. His work in humans is focusing on lean, obese and malnourished twins in order to obtain a deeper understanding of how we acquire our gut microbes, the genomic and metabolic underpinnings of their beneficial relationships with us, and how they help shape the nutritional needs of humans living in various parts of the world.
Gordon earned a bachelor's degree from Oberlin College, a medical degree from the University of Chicago and completed post-doctoral research at the National Institutes of Health. He has been on the faculty since 1981 and has mentored about 100 doctoral and M.D./Ph.D. students and post-doctoral fellows. His many honors include election to the National Academy of Sciences and the American Academy of Arts & Sciences. He has published 400 research papers and holds 23 U.S. patents.
Holtzman is known as one of the leading experts in researching the underlying mechanisms that lead to Alzheimer's disease in an effort to improve diagnosis and treatment. In addition to seeing patients at the Alzheimer's Disease Research Center and the Memory Diagnostic Center, Holtzman leads a research team working with animal models of Alzheimer's and works closely with the Washington University Alzheimer's Disease Research Center. His group has been instrumental in revealing mechanisms underlying how dangerous amounts of a protein called amyloid-beta (Abeta) begin to accumulate in the brain many years before symptoms arise. These basic science investigations have evolved over the years and are beginning to bridge the gap into the clinical arena.
Holtzman earned bachelors and medical degrees from Northwestern University. He completed an internship, residency and post-doctoral fellowship at the University of California, San Francisco, where he established the Memory and Cognitive Disorders Clinic and was assistant professor of neurology from 1991-1994, before joining the faculty at Washington University.
Past honors include the MetLife Foundation award for research on Alzheimer's Disease, a MERIT award from the National Institute on Aging and being selected as one of the Scientific American 50. He has published hundreds of papers in peer-reviewed journals, teaches medical students and supervises post-doctoral trainees.
Gordon and Holtzman are among 65 members whose elections to the Institute of Medicine were announced by the National Academy of Sciences Oct. 13. As members, Gordon and Holtzman make a commitment to devote a significant amount of volunteer time on committees engaged in a broad range of health-policy issues.
Two faculty members at Washington University School of Medicine in St. Louis have been elected to the Institute of Medicine of the National Academy of Sciences, one of the highest honors medical scientists in the United States can receive.
Jeffrey I. Gordon, M.D., and David M. Holtzman, M.D., were recognized for their major contributions to the advancement of the medical sciences, health care and public health and commitment to service.
Gordon is the Dr. Robert J. Glaser Distinguished University Professor and director of the Center for Genome Sciences, and Holtzman is the Andrew B. and Gretchen P. Jones Professor and chair of the Department of Neurology.
Gordon is internationally known for his research on gut development and how gut microbes affect normal intestinal function, and predisposition to health and to certain diseases. His research has shown that our gut microbes are biomarkers, mediators and potential therapeutic targets in the war against the worldwide obesity epidemic. By sequencing the genes present in gut microbial communities of obese and lean mice, and by observing the effects of transplanting these communities into germ-free mice, he has shown that microbial communities from obese mice have an increased capacity to harvest calories from the diet. His work in humans is focusing on lean, obese and malnourished twins in order to obtain a deeper understanding of how we acquire our gut microbes, the genomic and metabolic underpinnings of their beneficial relationships with us, and how they help shape the nutritional needs of humans living in various parts of the world.
Gordon earned a bachelor's degree from Oberlin College, a medical degree from the University of Chicago and completed post-doctoral research at the National Institutes of Health. He has been on the faculty since 1981 and has mentored about 100 doctoral and M.D./Ph.D. students and post-doctoral fellows. His many honors include election to the National Academy of Sciences and the American Academy of Arts & Sciences. He has published 400 research papers and holds 23 U.S. patents.
Holtzman is known as one of the leading experts in researching the underlying mechanisms that lead to Alzheimer's disease in an effort to improve diagnosis and treatment. In addition to seeing patients at the Alzheimer's Disease Research Center and the Memory Diagnostic Center, Holtzman leads a research team working with animal models of Alzheimer's and works closely with the Washington University Alzheimer's Disease Research Center. His group has been instrumental in revealing mechanisms underlying how dangerous amounts of a protein called amyloid-beta (Abeta) begin to accumulate in the brain many years before symptoms arise. These basic science investigations have evolved over the years and are beginning to bridge the gap into the clinical arena.
Holtzman earned bachelors and medical degrees from Northwestern University. He completed an internship, residency and post-doctoral fellowship at the University of California, San Francisco, where he established the Memory and Cognitive Disorders Clinic and was assistant professor of neurology from 1991-1994, before joining the faculty at Washington University.
Past honors include the MetLife Foundation award for research on Alzheimer's Disease, a MERIT award from the National Institute on Aging and being selected as one of the Scientific American 50. He has published hundreds of papers in peer-reviewed journals, teaches medical students and supervises post-doctoral trainees.
Gordon and Holtzman are among 65 members whose elections to the Institute of Medicine were announced by the National Academy of Sciences Oct. 13. As members, Gordon and Holtzman make a commitment to devote a significant amount of volunteer time on committees engaged in a broad range of health-policy issues.
Thursday, October 2, 2008
Biden, Palin set for Oct. 2 VP Debate- TONIGHT!
Sen. Joe Biden from Delaware and Gov. Sarah Palin of Alaska, the vice presidential nominees of the Democratic and Republican parties, respectively, will debate each other at 8 p.m. (CDT) Oct. 2 in the Washington University in St. Louis Athletic Complex, according to the Commission on Presidential Debates (CPD).
This is the first time the University will host a vice presidential debate. It's the fifth consecutive presidential election that the University has been selected by the CPD, the event's sponsor, to serve as a debate host.
The debate will be moderated by Gwen Ifill, a longtime correspondent and moderator for nationally televised public broadcasting news programs. Ifill, who serves as moderator and managing editor of PBS' "Washington Week" and senior correspondent for "The NewsHour with Jim Lehrer," also moderated the CPD's 2004 vice presidential debate between Vice President Dick Cheney and Sen. John Edwards, held Oct. 5 at Case Western Reserve University in Cleveland.
Biden was nominated for vice president Aug. 27 at the Democratic National Convention in Denver, Colo. A week later, on Sept. 4, Palin was nominated for vice president at the Republican National Convention in St. Paul, Minn.
Biden, 65, is a 36-year veteran of the U.S. Senate. He was elected in 1972 when he was 29. He is known for his leadership in foreign policy, terrorism, crime and drug policy. He ran unsuccessfully for the presidential nomination of his party in 1988 and in 2008.
Biden is the former chairman and long-time member of the Senate Judiciary Committee. Over the years he has been influential in crime and drug policy legislation. His Violent Crime Control and Law Enforcement Act of 1994, frequently referred to as the Biden Crime Bill, increased police numbers by 100,000 nationwide and brought more federal support for criminal justice.
The 2007 Biden Crime Bill addresses burgeoning crime problems such as online child exploitation, computer hacking and teenage prescription drug abuse.
Palins vice presidential nomination marks the first time that the Republican Party has nominated a woman for the position. On Dec. 4, 2006, she also made history when she became the first woman governor of Alaska.
Palin, 44, has overseen increases in Alaska state savings, education funding and implemented the Senior Benefits Program that provides support for low-income older Alaskans. Her administration has passed an overhaul of the states ethics laws and developed a process to construct a gas pipeline.
Palin is chair of the Interstate Oil and Gas Compact Commission, a multistate government agency that promotes the conservation and efficient recovery of domestic oil and natural gas resources while protecting the environment.
Before becoming governor of Alaska, she served two terms on the Wasilla City Council and two terms as mayor/manager of Wasilla. Palin also has served as chair of the Alaska Conservation Commission, which regulates Alaska's oil and gas.
Washington University is the only institution to host more than two debates.
In 1992, the university hosted the first nationally televised three-candidate presidential debate in CPD history, was selected to host a presidential debate in 1996 that eventually was canceled, hosted the third and last presidential debate of the 2000 campaign season and the second of three presidential debates before the 2004 election.
This is the first time the University will host a vice presidential debate. It's the fifth consecutive presidential election that the University has been selected by the CPD, the event's sponsor, to serve as a debate host.
The debate will be moderated by Gwen Ifill, a longtime correspondent and moderator for nationally televised public broadcasting news programs. Ifill, who serves as moderator and managing editor of PBS' "Washington Week" and senior correspondent for "The NewsHour with Jim Lehrer," also moderated the CPD's 2004 vice presidential debate between Vice President Dick Cheney and Sen. John Edwards, held Oct. 5 at Case Western Reserve University in Cleveland.
Biden was nominated for vice president Aug. 27 at the Democratic National Convention in Denver, Colo. A week later, on Sept. 4, Palin was nominated for vice president at the Republican National Convention in St. Paul, Minn.
Biden, 65, is a 36-year veteran of the U.S. Senate. He was elected in 1972 when he was 29. He is known for his leadership in foreign policy, terrorism, crime and drug policy. He ran unsuccessfully for the presidential nomination of his party in 1988 and in 2008.
Biden is the former chairman and long-time member of the Senate Judiciary Committee. Over the years he has been influential in crime and drug policy legislation. His Violent Crime Control and Law Enforcement Act of 1994, frequently referred to as the Biden Crime Bill, increased police numbers by 100,000 nationwide and brought more federal support for criminal justice.
The 2007 Biden Crime Bill addresses burgeoning crime problems such as online child exploitation, computer hacking and teenage prescription drug abuse.
Palins vice presidential nomination marks the first time that the Republican Party has nominated a woman for the position. On Dec. 4, 2006, she also made history when she became the first woman governor of Alaska.
Palin, 44, has overseen increases in Alaska state savings, education funding and implemented the Senior Benefits Program that provides support for low-income older Alaskans. Her administration has passed an overhaul of the states ethics laws and developed a process to construct a gas pipeline.
Palin is chair of the Interstate Oil and Gas Compact Commission, a multistate government agency that promotes the conservation and efficient recovery of domestic oil and natural gas resources while protecting the environment.
Before becoming governor of Alaska, she served two terms on the Wasilla City Council and two terms as mayor/manager of Wasilla. Palin also has served as chair of the Alaska Conservation Commission, which regulates Alaska's oil and gas.
Washington University is the only institution to host more than two debates.
In 1992, the university hosted the first nationally televised three-candidate presidential debate in CPD history, was selected to host a presidential debate in 1996 that eventually was canceled, hosted the third and last presidential debate of the 2000 campaign season and the second of three presidential debates before the 2004 election.
For additional information on the October 2 debate, please click here.
Subscribe to:
Posts (Atom)